Form4insider filings, from the source

SEC Form 4 · accession 0000874015-17-000010

IONIS PHARMACEUTICALS INC · IONS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Richard S Geary
Officer — SVP, Development
Period of report
Jan 15, 2017
Accepted (ET)
Jan 18, 2017 · 6:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 15, 2017M1,397$0.00A10,554D
Common StockF2Jan 17, 2017S546$46.291D10,008D
Common StockF3Jan 15, 2017M1,875$0.00A11,883D
Common StockF4Jan 17, 2017S733$46.291D11,150D
Common StockF5Jan 15, 2017M1,380$0.00A12,530D
Common StockF6Jan 17, 2017S539$46.29D11,991D
Common StockF7Jan 15, 2017M1,594$0.00A13,585D
Common StockF8Jan 17, 2017S623$46.291D12,962D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF9,F10—Jan 15, 2017A7,537A——Common Stock7,5377,537D
Restricted Stock UnitsF2,F9,F11—Jan 15, 2017M1,397D——Common Stock1,3970D
Restricted Stock UnitsF4,F9,F11—Jan 15, 2017M1,875D——Common Stock1,8751,875D
Restricted Stock UnitsF6,F9,F11—Jan 15, 2017M1,380D——Common Stock1,3802,758D
Restricted Stock UnitsF8,F9,F11—Jan 15, 2017M1,594D——Common Stock1,5944,779D

Explanation of responses